PLEKHM2 and heart failure: •The patient's progression from heart failure to critical cardiogenic shock and the rare PLEKHM2 mutation underscore the complexity of advanced heart failure therapies, including extracorporeal membrane oxygenation, LVAD, and heart transplantation.